Hyperpigmentation describes increased pigmentation that makes an area of skin appear darker than the surrounding tissue. In aesthetic practice, common presentations include solar lentigines, melasma and post-inflammatory hyperpigmentation following acne, irritation, injury or procedures.
Although clients may describe all dark marks as “pigmentation”, the underlying cause matters. A practitioner-led assessment should consider the pattern, onset, skin phototype, previous inflammation or procedures, hormonal history where relevant, sun exposure and any features that make a lesion unsuitable for cosmetic management.
Understanding Hyperpigmentation
Melanin is produced by melanocytes and contributes to normal skin colour and photoprotection. Hyperpigmentation develops when melanin production or distribution increases in a localised or more diffuse pattern. It can affect all skin tones, while post-inflammatory pigmentation and some pigment disorders can be more persistent or prominent in darker phototypes.
The practical question is not simply whether pigment is present, but what pattern of pigmentation the practitioner is seeing and what has driven it.
Common Pigmentation Presentations
Solar lentigines
Discrete, usually well-defined brown macules that develop on chronically sun-exposed skin. These form part of a broader photodamage picture and should be distinguished from lesions that require medical assessment.
Melasma
Acquired symmetrical hyperpigmentation most commonly affecting the face. Hormonal influences, genetics and ultraviolet or visible-light exposure can contribute, and recurrence is common.
Post-inflammatory hyperpigmentation
Pigmentation that follows inflammation or injury, including acne, irritation and some aesthetic procedures. The risk and persistence of PIH should be considered when planning resurfacing or energy-based treatments.
Freckling and other pigment variation
Freckles and constitutional pigment patterns may become more visible with ultraviolet exposure. Practitioners should avoid assuming that every pigmented lesion is suitable for cosmetic treatment.
Practitioner Considerations
-
Record onset, distribution, pattern and any recent change
-
Ask about acne, inflammation, procedures or skin injury that may have preceded the pigmentation
-
Consider hormonal factors and pregnancy history where relevant to melasma
-
Assess Fitzpatrick phototype and previous history of post-inflammatory pigmentation when planning procedures
-
Review current products, medications and photosensitising factors where relevant
-
Do not cosmetically treat a pigmented lesion that is new, changing, symptomatic or diagnostically uncertain; seek appropriate medical assessment
Supporting Pigmentation with Professional Skincare
Pigmentation programmes work best when they address both the visible pigment and the factors that can continue to stimulate it. For many clients, consistent photoprotection and a tolerable long-term skincare plan are as important as the corrective phase.
-
Broad-spectrum photoprotection and attention to ongoing UV exposure
-
Pigment-regulating or brightening ingredients selected according to product status and practitioner scope
-
Retinoid or exfoliating strategies when appropriate to tolerance and prescription status
-
Barrier support to reduce avoidable inflammation that could worsen PIH
-
Careful sequencing of peels, devices or other procedures in clients with a history of pigmentation
-
Maintenance planning to reduce recurrence rather than treating pigmentation as a one-off event
Healthxchange Portfolio Options for Hyperpigmentation
Pigmentation programmes need to reflect the type of discolouration, skin tone, inflammatory history, UV exposure and risk of post-inflammatory hyperpigmentation. Healthxchange’s portfolio gives practitioners several ways to support this concern without making one brand the default for every client.
Skincare and make-up
Obagi and Medik8 can support practitioner-led pigmentation, antioxidant, renewal and photoprotection programmes. Jane Iredale may be relevant where visible discolouration creates a need for complexion, camouflage or SPF support. Epicutis can complement more active programmes where hydration and barrier recovery are important, while Dr Levy may be considered when pigmentation sits alongside broader ageing and skin-quality concerns.
Assessment and procedural support
OBSERV can support pigmentation assessment and documentation during consultation. Clinisept may be considered within appropriate pre- or post-procedure skin-hygiene protocols. Where texture, photoageing or other skin-quality concerns coexist, Potenza or UltraLUX may form part of a wider treatment pathway when clinically appropriate and within practitioner training.
Pigmentation can be complex, particularly in clients with a history of melasma or post-inflammatory hyperpigmentation. Product and procedure selection should therefore be conservative, individualised and supported by appropriate training.
Build Your Pigmentation Knowledge
The Healthxchange Academy Hyperpigmentation course covers types of pigmentation, causes, the Fitzpatrick scale and recommended product approaches. Practitioners can also progress to Obagi Best Practice and Advanced Learning for more advanced pigmentation, acne and rosacea protocol discussion.